bupivacaine hydrochloride + triamcinolone acetonide + isopropyl alcohol + dexamethasone sodium

This appears to be a **multi-ingredient compounded or kit-style local injection regimen** combining **bupivacaine hydrochloride** as a long-acting amide local anesthetic with **triamcinolone acetonide** and **dexamethasone sodium** as corticosteroid anti-inflammatory agents; **isopropyl alcohol** functions as a topical skin antiseptic rather than a therapeutic active ingredient in the injected product. Mechanistically, bupivacaine blocks voltage-gated sodium channels to inhibit nerve conduction and provide local anesthesia, while triamcinolone acetonide and dexamethasone activate the glucocorticoid receptor to suppress inflammatory gene expression and reduce pain and inflammation. The exact four-component combination name provided is not identifiable as a standard INN, approved branded product, or clearly verifiable single pharmaceutical asset in public sources; instead, available public evidence supports related kit products and procedural mixtures involving some of these ingredients rather than this exact named combination.

Other names

bupivacaine hydrochloride + triamcinolone acetonide + isopropyl alcohol + dexamethasone sodium